Pre-analytical protocol for measuring Alzheimer's disease biomarkers in fresh CSF.

Oskar HanssonSandra RutzHenrik ZetterbergEkaterina BauerTeresa HählEkaterina ManuilovaMehmet Can MertSimone WahlKaj BlennowErik Stomrud

Published in: Alzheimer's & dementia (Amsterdam, Netherlands) (2020)

We propose an easy-to-use, standardized, routine-use pre-analytical protocol, using low-bind FBTs, for measuring AD CSF biomarkers in clinical practice.

Keyphrases

clinical practice
randomized controlled trial
liquid chromatography
cognitive decline
mass spectrometry